official-gottfried-211x300-2446356As the Assembly voted Thursday to establish a statewide single-payer health system, supporters repeatedly insisted that their plan would save money for 98 percent of New Yorkers.

That claim does not come close to adding up, even based on the dubious financial estimates used by the plan’s chief sponsor, Assembly Health Chairman Richard Gottfried (photo).

A simple analysis of projected tax rates from economist Gerald Friedmanwhom Gottfried cites as authoritative—shows that taxpayers with incomes of $90,000 and up would pay more than the current average cost for health coverage. That alone translates to more than 10 percent of taxpayers who would be financially worse off under the New York Health Act.

screen-shot-2018-06-15-at-4-34-47-pm-6174343
(Click to enlarge)

This analysis focuses on just one of the two taxes the act would impose, on payroll income. It does not include the impact of a second tax on dividends, interest and capital gains. It also assumes that the state would need only $92 billion in additional revenue to finance the plan, as Friedman dubiously asserts.

Other analysts have estimated the cost of the New York Health Act at more than $200 billion. If that’s the case—or as costs rise over time—the share of New Yorkers who would be losers from single-payer would likely grow.

Although the New York Health Act would radically transform the state’s entire health care system, no one in the Legislature has produced an analysis of its costs and other effects. Gottfried has instead relied on a 2015 paper by Friedman, a professor at the University of Massachusetts at Amherst and a consistent supporter of single-payer health care.

The legislation itself did not specify exact tax rates—leaving them to be determined later—but Gottfried commonly uses rates projected by Friedman when discussing his bill. Those rates are in turn based on Friedman’s questionable estimate that the state would need about $92 billion in additional revenue (on top of the $78 billion in taxes it already collects).

Friedman’s proposed payroll tax would be steeply progressive: 0 percent up to $25,000, 9 percent up to $50,000, 11 percent up to $75,000, 12 percent up to $100,000, 14 percent up to $200,000, and 16 percent from $200,000 up. Employers would pay 80 percent of this levy, and employees would contribute 20 percent.

Using those rates, the total payroll tax would surpass the total average single premium for employer-sponsored insurance ($6,614 as of 2016) at around $89,000 in income (see chart). The employee share of the tax would surpass the average employee premium contribution ($1,357) at about $90,000 in income.

According to data from the Bureau of Labor Statistics, that threshold falls between the 75th and 90th percentiles for annual wages in New York as of 2017. That means the share of wage earners who would be worse off under the New York Health Act—based on the payroll tax alone—is somewhere between 10 percent and 25 percent.

The claim that 98 percent of New Yorkers would save money also comes from Friedman’s paper. Although he does not provide details, he asserts that the New York Health Act would reduce total health care costs for people with incomes up to $436,000 a year. As discussed above, that does not appear to be consistent with his own projected tax rates and the available data on average premiums. Even for family coverage (as opposed to single coverage) the payroll tax exceeds the average total premium starting at incomes of around $182,000.

This inconsistency is yet more reason not to trust too-good-to-be-true predictions about single-payer.

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

A Medicaid Grant Recipient Sponsors a Pro-Hochul Publicity Campaign

While much of the health-care industry is attacking Governor Hochul's Medicaid budget, at least one organization is rallying to her side: Somos Community Care, a politically active medical group in the Bronx that recently r Read More

Loss of Patients and Revenue Foreshadowed Downsizing for SUNY Downstate

The SUNY-owned hospital in Brooklyn facing a newly announced downsizing plan has seen its patient volume and revenue plunge over the past decade, according to a review of its financial reports. Read More

How a Medicaid Program To Improve Nursing Home Care Ended Up Paying for Union Benefits

New York State's budget-making process sometimes works like a closed loop, as interest groups on the receiving end of state spending reinvest a portion of their proceeds to lobby Albany for still more money. Read More

Despite Lingering Shortages, New York’s Health-Care Workforce Is Bigger Than Ever

The state's health-care workforce is recovering unevenly from the pandemic, with persistently lower employment levels in some areas and robust growth in others. This mixed pattern c Read More

The Wacky Math of New York’s Essential Plan

Thanks to an absurdly wasteful federal law, New York's Essential Plan is expected to continue running billion-dollar surpluses even as state officials more than double its spending over the next several years. Read More

In a Tight Budget Year, New York’s Hospital Lobby Shoots for the Moon

As Governor Hochul calls for spending restraint next year, influential hospital lobbyists are pushing what could be the costliest budget request ever floated in Albany. In a , the G Read More

Putting the Mission in Hochul’s Health Commission

Last week Governor Hochul answered one big question about her Commission on the Future of Health Care – the names of its members – but left a fundamental mystery unresolved:  W Read More

Medicaid Drug ‘Carve-Out’ Led to Double Payments

The state's Medicaid program has effectively been double-paying for prescription drugs for the past six months due to a glitch with the roll-out of its pharmacy "carve-out." Since A Read More